142 related articles for article (PubMed ID: 9636382)
1. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
[No Abstract] [Full Text] [Related]
2. In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents.
Degiannis D; Koniavitou K
Transplant Proc; 1996 Dec; 28(6):3062-4. PubMed ID: 8962187
[No Abstract] [Full Text] [Related]
3. Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin.
Hornung N; Raskova J; Raska K; Degiannis D
Transplantation; 1993 Oct; 56(4):985-90. PubMed ID: 7692641
[TBL] [Abstract][Full Text] [Related]
4. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus.
Combates NJ; Degiannis D; Raskova J; Raska K
Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731
[TBL] [Abstract][Full Text] [Related]
5. IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies.
Baan CC; Boelaars-van Haperen MJ; van Riemsdijk IC; van der Plas AJ; Weimar W
Transplant Proc; 2001 May; 33(3):2244-6. PubMed ID: 11377516
[No Abstract] [Full Text] [Related]
6. Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs.
Vathsala A; Chin YM; Noraiza I; Sun L
Transplant Proc; 2000 Nov; 32(7):1992-4. PubMed ID: 11120034
[No Abstract] [Full Text] [Related]
7. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells.
Kim HS; Raskova J; Degiannis D; Raska K
Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
Nakajima H; Oka T
Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
[No Abstract] [Full Text] [Related]
9. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
10. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
[No Abstract] [Full Text] [Related]
11. Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals.
Willems F; Andris F; Abramowicz D; Piérard G; Wissing M; Leo O; Goldman M
Transplant Proc; 1995 Feb; 27(1):1425-7. PubMed ID: 7878934
[No Abstract] [Full Text] [Related]
12. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
Chae DW; Nosaka Y; Strom TB; Maslinski W
J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384
[TBL] [Abstract][Full Text] [Related]
13. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
Mattila PS
Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
[No Abstract] [Full Text] [Related]
14. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer HH
Transplant Proc; 1998 Aug; 30(5):2195-7. PubMed ID: 9723438
[No Abstract] [Full Text] [Related]
15. Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay.
Kimball P; Kerman RH; Williams J; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):518-9. PubMed ID: 8438397
[No Abstract] [Full Text] [Related]
16. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
Luo H; Chen H; Daloze P; Chang J; Wu J
Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
[No Abstract] [Full Text] [Related]
17. Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment.
Strehlau J; Maslinski W; Chae D; Pavlakis M; Ehrich JH; Strom TB
Transplant Proc; 1998 Aug; 30(5):2389-91. PubMed ID: 9723514
[No Abstract] [Full Text] [Related]
18. Analysis of biochemical and biological functions of Fas-ligand (FasL) and Fas on activated T cells in allo-immune response.
Nakajima H; Oka T
Transplant Proc; 1997; 29(1-2):1096-100. PubMed ID: 9123217
[No Abstract] [Full Text] [Related]
19. Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction.
Nelson PA; Kawamura A; Akselband Y; Peattie DA; Aldape RA; Harding MW
Transplant Proc; 1991 Dec; 23(6):2867-9. PubMed ID: 1721299
[No Abstract] [Full Text] [Related]
20. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.
Haczku A; Alexander A; Brown P; Assoufi B; Li B; Kay AB; Corrigan C
J Allergy Clin Immunol; 1994 Feb; 93(2):510-9. PubMed ID: 8120277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
